Patents Assigned to Cancer Research Technology, LLC
  • Methods and compositions for gamma-glutamyl cycle modulation
    Patent number: 11186555
    Abstract: The present disclosure provides pharmaceutical compositions comprising Gamma-glutamyl cycle inhibitors (GGCI) and certain pharmaceutically acceptable salts thereof, and methods of use.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: November 30, 2021
    Assignee: CANCER RESEARCH TECHNOLOGY, LLC
    Inventors: David Rubin, Eyal Rubin
  • Methods and compositions for gamma-glutamyl cycle modulation
    Patent number: 9630936
    Abstract: The present disclosure provides pharmaceutical compositions comprising Gamma-glutamyl cycle inhibitors (GGCI) and certain pharmaceutically acceptable salts thereof, and methods of use.
    Type: Grant
    Filed: March 15, 2014
    Date of Patent: April 25, 2017
    Assignee: Cancer Research Technology, LLC
    Inventors: David Rubin, Eyal Rubin
  • METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION
    Publication number: 20140275187
    Abstract: The present disclosure provides pharmaceutical compositions comprising Gamma-glutamyl cycle inhibitors (GGCI) and certain pharmaceutically acceptable salts thereof, and methods of use.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 18, 2014
    Applicant: Cancer Research Technology, LLC
    Inventors: David RUBIN, Eyal RUBIN